Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleAdult Brain

FDG-PET and MRI in the Evolution of New-Onset Refractory Status Epilepticus

T. Strohm, C. Steriade, G. Wu, S. Hantus, A. Rae-Grant and M. Larvie
American Journal of Neuroradiology February 2019, 40 (2) 238-244; DOI: https://doi.org/10.3174/ajnr.A5929
T. Strohm
aFrom the Department of Neurology (T.S.), Neurovascular Stroke Center, Ohio State University, Columbus, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for T. Strohm
C. Steriade
bDepartment of Epilepsy (C.S., S.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Steriade
G. Wu
cDepartment of Nuclear Medicine (G.W., M.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G. Wu
S. Hantus
bDepartment of Epilepsy (C.S., S.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Hantus
A. Rae-Grant
eDepartment of Neuroimmunology (A.R.-G.), Cleveland Clinic, Cleveland, Ohio.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A. Rae-Grant
M. Larvie
cDepartment of Nuclear Medicine (G.W., M.L.)
dDepartment of Neuroradiology (M.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Larvie
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

References

  1. 1.↵
    1. Gaspard N,
    2. Foreman BP,
    3. Alvarez V, et al
    ; Critical Care EEG Monitoring Research Consortium (CCEMRC). New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology 2015;85:1604–13 doi:10.1212/WNL.0000000000001940 pmid:26296517
    CrossRefPubMed
  2. 2.↵
    1. Hirsch LJ,
    2. Gaspard N,
    3. van Baalen A, et al
    . Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia 2018;59:739–44 doi:10.1111/epi.14016 pmid:29399791
    CrossRefPubMed
  3. 3.↵
    1. Graus F,
    2. Titulaer MJ,
    3. Balu R, et al
    . A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016;15:391–404 doi:10.1016/S1474-4422(15)00401-9 pmid:26906964
    CrossRefPubMed
  4. 4.↵
    1. Ismail FY,
    2. Kossoff EH
    . AERRPS, DESC, NORSE, FIRES: Multi-labeling or distinct epileptic entities? Epilepsia 2011;52:e185–89 doi:10.1111/j.1528-1167.2011.03293.x pmid:22004046
    CrossRefPubMed
  5. 5.↵
    1. Sakuma H,
    2. Awaya Y,
    3. Shiomi M, et al
    . Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis. Acta Neurol Scand 2010;121:251–56 doi:10.1111/j.1600-0404.2009.01198.x pmid:20028339
    CrossRefPubMedWeb of Science
  6. 6.↵
    1. Costello DJ,
    2. Kilbride RD,
    3. Cole AJ
    . Cryptogenic new onset refractory status epilepticus (NORSE) in adults: infectious or not? J Neurol Sci 2009;277:26–31 doi:10.1016/j.jns.2008.10.007 pmid:19013586
    CrossRefPubMed
  7. 7.↵
    1. Byun J,
    2. Lee S,
    3. Jung K, et al
    . Effect of immunotherapy on seizure outcome in patients with autoimmune encephalitis: a prospective observational registry study. PLoS One 2016;11:e0146455 doi:10.1371/journal.pone.0146455 pmid:26771547
    CrossRefPubMed
  8. 8.↵
    1. Gall CR,
    2. Jumma O,
    3. Mohanraj R
    . Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy. Seizure 2013;22:217–20 doi:10.1016/j.seizure.2012.12.016 pmid:23333762
    CrossRefPubMed
  9. 9.↵
    1. Iizuka T,
    2. Kanazawa N,
    3. Kaneko J, et al
    . Cryptogenic NORSE: its distinctive clinical features and response to immunotherapy. Neurol Neuroimmunol Neuroinflamm 2017;4:e396 doi:10.1212/NXI.0000000000000396 pmid:28959704
    Abstract/FREE Full Text
  10. 10.↵
    1. Khawaja AM,
    2. DeWolfe JL,
    3. Miller DW, et al
    . New-onset refractory status epilepticus (NORSE): the potential role for immunotherapy. Epilepsy Behav 2015;47:17–23 doi:10.1016/j.yebeh.2015.04.054 pmid:26010959
    CrossRefPubMed
  11. 11.↵
    1. Li J,
    2. Saldivar C,
    3. Maganti RK
    . Plasma exchange in cryptogenic new onset refractory status epilepticus. Seizure 2013;22:70–73 doi:10.1016/j.seizure.2012.09.011 pmid:23068971
    CrossRefPubMed
  12. 12.↵
    1. Kenney-Jung DL,
    2. Vezzani A,
    3. Kahoud RJ, et al
    . Febrile infection-related epilepsy syndrome treated with anakinra. Ann Neurol 2016;80:939–45 doi:10.1002/ana.24806 pmid:27770579
    CrossRefPubMed
  13. 13.↵
    1. Leypoldt F,
    2. Buchert R,
    3. Kleiter I, et al
    . Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry 2012;83:681–86 doi:10.1136/jnnp-2011-301969 pmid:22566598
    Abstract/FREE Full Text
  14. 14.↵
    1. Titulaer M,
    2. Soffietti R,
    3. Dalmau J, et al
    ; European Federation of Neurological Societies. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 2011;18:19-e3 doi:10.1111/j.1468-1331.2010.03220.x pmid:20880069
    CrossRefPubMed
  15. 15.↵
    1. Cole AJ
    . Status epilepticus and periictal imaging. Epilepsia 2004;45:72–77 pmid:15281962
    CrossRefPubMed
  16. 16.↵
    1. Kim S,
    2. Mountz JM
    . SPECT imaging of epilepsy: an overview and comparison with F-18 FDG PET. Int J Mol Imaging 2011;2011:813028 doi:10.1155/2011/813028 pmid:21785722
    CrossRefPubMed
  17. 17.↵
    1. Sarria-Estrada S,
    2. Toledo M,
    3. Lorenzo-Bosquet C, et al
    . Neuroimaging in status epilepticus secondary to paraneoplastic autoimmune encephalitis. Clin Radiol 2014;69:795–803 doi:10.1016/j.crad.2014.03.012 pmid:24824979
    CrossRefPubMed
  18. 18.↵
    1. Baumgartner A,
    2. Rauer S,
    3. Mader I, et al
    . Cerebral FDG PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol 2013;260:2744–53 doi:10.1007/s00415-013-7048-2 pmid:23900756
    CrossRefPubMed
  19. 19.↵
    1. Probasco JC,
    2. Solnes L,
    3. Nalluri A, et al
    . Abnormal brain metabolism on FDG PET/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 2017;4:e352 doi:10.1212/NXI.0000000000000352 pmid:28567435
    CrossRefPubMed
  20. 20.↵
    1. Finke C,
    2. Prüss H,
    3. Heine J, et al
    . Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 2017;74:50–59 doi:10.1001/jamaneurol.2016.4226 pmid:27893017
    CrossRefPubMed
  21. 21.↵
    1. Heine J,
    2. Prüss H,
    3. Bartsch T, et al
    . Imaging of autoimmune encephalitis–relevance for clinical practice and hippocampal function. Neuroscience 2015;309:68–83 doi:10.1016/j.neuroscience.2015.05.037 pmid:26012492
    CrossRefPubMed
  22. 22.↵
    1. Miller TD,
    2. Chong TT,
    3. Aimola Davies AM, et al
    . Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis. Brain 2017;140:1212–19 doi:10.1093/brain/awx070 pmid:28369215
    CrossRefPubMed
  23. 23.↵
    1. Wagner J,
    2. Schoene-Bake J,
    3. Malter MP, et al
    . Quantitative FLAIR analysis indicates predominant affection of the amygdala in antibody-associated limbic encephalitis. Epilepsia 2013;54:1679–87 doi:10.1111/epi.12320 pmid:23889589
    CrossRefPubMed
  24. 24.↵
    1. Khan NL,
    2. Jeffree MA,
    3. Good C, et al
    . Histopathology of VGKC antibody-associated limbic encephalitis. Neurology 2009;72:1703–05 doi:10.1212/WNL.0b013e3181a55eb3 pmid:19433746
    FREE Full Text
  25. 25.↵
    1. Vincent A,
    2. Bien CG,
    3. Irani SR, et al
    . Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011;10:759–72 doi:10.1016/S1474-4422(11)70096-5 pmid:21777830
    CrossRefPubMedWeb of Science
  26. 26.↵
    1. Maeder-Ingvar M,
    2. Prior JO,
    3. Irani SR, et al
    . FDG PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis. J Neurol Neurosurg Psychiatry 2011;82:235–36 doi:10.1136/jnnp.2009.198697 pmid:20667855
    FREE Full Text
  27. 27.↵
    1. Probasco JC,
    2. Solnes L,
    3. Nalluri A, et al
    . Decreased occipital lobe metabolism by FDG PET/CT: an antip-NMDA receptor encephalitis biomarker. Neurol Neuroimmunol Neuroinflamm 2018;5:e413 doi:10.1212/NXI.0000000000000413 pmid:29159205
    CrossRefPubMed
  28. 28.↵
    1. Dodich A,
    2. Cerami C,
    3. Iannaccone S, et al
    . Neuropsychological and FDG-PET profiles in VGKC autoimmune limbic encephalitis. Brain Cogn 2016;108:81–87 doi:10.1016/j.bandc.2016.07.010 pmid:27566001
    CrossRefPubMed
  29. 29.↵
    1. Quartuccio N,
    2. Caobelli F,
    3. Evangelista L, et al
    ; Young AIMN Working Group. The role of FDG PET/CT in the evaluation of patients affected by limbic encephalitis: a systematic review of the literature. J Neuroimmunol 2015;284:44–48 doi:10.1016/j.jneuroim.2015.05.002 pmid:26025057
    CrossRefPubMed
  30. 30.↵
    1. Mazzuca M,
    2. Jambaque I,
    3. Hertz-Pannier L, et al
    . 18F-FDG PET reveals frontotemporal dysfunction in children with fever-induced refractory epileptic encephalopathy. J Nucl Med 2011;52:40–47 doi:10.2967/jnumed.110.077214 pmid:21149491
    Abstract/FREE Full Text
  31. 31.↵
    1. Nardetto L,
    2. Zoccarato M,
    3. Santelli L, et al
    . (18)F-FDG PET/MRI in cryptogenic new-onset refractory status epilepticus: a potential marker of disease location, activity and prognosis? J Neurol Sci 2017;381:100–02 doi:10.1016/j.jns.2017.08.021 pmid:28991656
    CrossRefPubMed
  32. 32.↵
    1. Kantanen A,
    2. Reinikainen M,
    3. Parviainen I, et al
    . Long-term outcome of refractory status epilepticus in adults: a retrospective population-based study. Epilepsy Res 2017;133:13–21 doi:10.1016/j.eplepsyres.2017.03.009 pmid:28402834
    CrossRefPubMed
  33. 33.↵
    1. Solnes LB,
    2. Jones KM,
    3. Rowe SP, et al
    . Diagnostic value of 18F-FDG PET/CT versus MRI in the setting of antibody-specific autoimmune encephalitis. J Nucl Med 2017;58:1307–13 doi:10.2967/jnumed.116.184333 pmid:28209905
    Abstract/FREE Full Text
  34. 34.↵
    1. Newey C,
    2. Sarwal A,
    3. Hantus S
    . [18F]-fluoro-deoxy-glucose positron emission tomography scan should be obtained early in cases of autoimmune encephalitis. Autoimmune Dis 2016;2016:9450452 doi:10.1155/2016/9450452 pmid:27559482
    CrossRefPubMed
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 40 (2)
American Journal of Neuroradiology
Vol. 40, Issue 2
1 Feb 2019
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FDG-PET and MRI in the Evolution of New-Onset Refractory Status Epilepticus
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
T. Strohm, C. Steriade, G. Wu, S. Hantus, A. Rae-Grant, M. Larvie
FDG-PET and MRI in the Evolution of New-Onset Refractory Status Epilepticus
American Journal of Neuroradiology Feb 2019, 40 (2) 238-244; DOI: 10.3174/ajnr.A5929

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
FDG-PET and MRI in the Evolution of New-Onset Refractory Status Epilepticus
T. Strohm, C. Steriade, G. Wu, S. Hantus, A. Rae-Grant, M. Larvie
American Journal of Neuroradiology Feb 2019, 40 (2) 238-244; DOI: 10.3174/ajnr.A5929
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref (19)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Brain 18F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis
    Manon Bordonne, Mohammad B. Chawki, Matthieu Doyen, Aurelie Kas, Eric Guedj, Louise Tyvaert, Antoine Verger
    European Journal of Nuclear Medicine and Molecular Imaging 2021 48 12
  • The etiology and mortality of new‐onset refractory status epilepticus (NORSE) in adults: A systematic review and meta‐analysis
    Thahesh Tharmaraja, Jamie Sin Ying Ho, Aidan Neligan, Sanjeev Rajakulendran
    Epilepsia 2023 64 5
  • The timelines of MRI findings related to outcomes in adult patients with new‐onset refractory status epilepticus
    Hyo Jae Kim, Sang‐Ahm Lee, Hyun‐Woo Kim, Soo Jeong Kim, Sang‐Beom Jeon, Yong Seo Koo
    Epilepsia 2020 61 8
  • Contribution of PET-MRI in brain diseases in clinical practice
    Nadya Pyatigorskaya, Marie-Odile Habert, Laura Rozenblum
    Current Opinion in Neurology 2020 33 4
  • The correspondence between morphometric MRI and metabolic profile in Rasmussen’s encephalitis
    Chongyang Tang, Peng Ren, Kaiqiang Ma, Siyang Li, Xiongfei Wang, Yuguang Guan, Jian Zhou, Tianfu Li, Xia Liang, Guoming Luan
    NeuroImage: Clinical 2022 33
  • Morphological and Advanced Imaging of Epilepsy: Beyond the Basics
    Aikaterini Fitsiori, Shivaprakash Basavanthaiah Hiremath, José Boto, Valentina Garibotto, Maria Isabel Vargas
    Children 2019 6 3
  • Functional outcomes of patients with NORSE and FIRES treated with immunotherapy: A systematic review
    P. Cabezudo-García, N. Mena-Vázquez, N.L. Ciano-Petersen, B. Oliver-Martos, P.J. Serrano-Castro
    Neurología (English Edition) 2024 39 8
  • Hemodynamic changes associated with common EEG patterns in critically ill patients: Pilot results from continuous EEG-fNIRS study
    Ali Kassab, Dènahin Hinnoutondji Toffa, Manon Robert, Frédéric Lesage, Ke Peng, Dang Khoa Nguyen
    NeuroImage: Clinical 2021 32
  • Hypometabolism of the left middle/medial frontal lobe onFDG‐PETin anti–NMDAreceptor encephalitis: Comparison withMRIandEEGfindings
    Chenpeng Zhang, Yong Hao, Gan Huang, Mei Xin, Shuwei Bai, Yangtai Guan, Jianjun Liu
    CNS Neuroscience & Therapeutics 2023 29 6
  • Inflammation as Treatment Target for Status Epilepticus
    Konrad Rejdak, Agata Pikulicka, Małgorzata Piekarska, Katarzyna Pacek, Kamila Płachta
    Current Neuropharmacology 2023 21 3

More in this TOC Section

  • Diagnostic Neuroradiology of Monoclonal Antibodies
  • Clinical Outcomes After Chiari I Decompression
  • Segmentation of Brain Metastases with BLAST
Show more ADULT BRAIN

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire